Showing 5 posts of 5 posts found.

uniQure announces sale of royalty interest in Hemgenix for up to $400m

May 16, 2023
Sales and Marketing Haematology, Hemgenix, haemophilia, royalties, uniQure

uniQure has announced that it has entered a definitive agreement to sell a portion of the royalty rights due to …

BMS image

BMS enters gene therapy development deal

April 7, 2015
Research and Development BMS, Bristol-Myers Squibb, R&D, cardiovascular disease, cvd, heart disease, heart failure, uniQure

Bristol-Myers Squibb (BMS) has signed a multi-million dollar agreement with Amsterdam-based gene therapy firm uniQure to boost research into new …


Manufacturing news in brief

August 5, 2013
Manufacturing and Production Fresenius Kabi, Gallus, NextPharma Technologies, PharmaForm, Sanofie Chimie, uniQure

New contracts for Sanofi and Gallus, Fresenius Kabi sacks Indian managers, facility news from UniQure and Nextpharma plus BiG’s acquisition …


uniQure appoints Basilea’s chief commercial officer

December 6, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Basilea, uniQure

Dutch human gene therapy firm uniQure has appointed Hans Christian Rohde as chief commercial officer. Rohde joins uniQure from Basilea …

uniQure's Glybera

EMA recommends first new gene therapy

July 24, 2012
Business Services, Research and Development, Sales and Marketing CHMP, EMA, Glybera, uniQure

Glybera is now on the cusp of becoming the first gene therapy treatment to be approved in the West. The …

Latest content